Kabi Introduces Idacio Into Crowded German Adalimumab Market

 
• By Aidan Fry
  
Germany
Kabi's Idacio will have to compete for share as the fifth adalimumab biosimilar to enter the German market • Source: Shutterstock

More from Biosimilars

More from Products